Warning

 

Close
Confirm Action

Are you sure you wish to do this?

Cancel Confirm
AR15.COM
12/15/2008 8:21:25 PM EDT
hey guys, where is the cheapest place to buy a few packs of this stuff? someone told me there is a few different generations? guess the newest doesn't cause burns to the skin.

i would also like to buy a tourniquet that you can apply yourself. "CAT"

thanks
12/15/2008 9:00:47 PM EDT
[#1]
In before the shitstorm....

And please read the standard QC thread caveat....

Some love it some hate it. It's a tool in a box that has it's place. It works well for some wounds, not well or at all for others. Knowing the difference is helpful. Don't negate the need for good quality pre QC application bleeding control. Don't negate the need for good wound packing. If done well and correctly you may not even need QC(or any other hemostatic agent) or tourniquet to stop the bleed. Have more than just QC and a tourniquet at your disposal. Take a good first aid/CFR/EMT class to really understand bleeding and how hemostatic agents fit into the bleeding control continuum. Save for soldiers, Marines, medics and corpsmen, a life threatening bleed in need of QC is maybe a once in the lifetime event. QC has a three year shelf life.

1st Gen QC burned, the ACS doesn't. HemCon is the bomb and TraumaDex sucks. Celox works too but not for huge wounds. Z-Medica has a sexy prduct and a sexy campaign. They market it to biker, hikers and anyone else who feels low speed without it, but most likely you can do without it. I have no clue what I'm talking about I read it all on the interwebs.


Whew...seriously. Just google it for pricing as no one offers stellar deals on it. So unless someone is selling it cheap as it's from their leftover gear from the .mil you'll pay retail. The same goes for the TKs. CAT is a good TK, check out the MAT and the SOF-T TKs as well. As with QC, some will swear by some TKs and others will swear at them. Just understand that the use of TKs is not as feared as it once was and earlier, more aggressive use isn't a bad thing.

Look into Israeli dressings and the Olaes Modular Bandages too. There's probably a few or fifty types that I'm unaware of or forgetting.

Or, just buy some 5x9s and a few ACE wraps for a lower speed equivalent that most likely will work just as well.

If you want a package deal, just hit the EE and buy an IFAK with all the goodies in them for pretty cheap. A CAT will run you 27-36 bucks. There's a guy selling two IFAKs for 45 a piece. That's with the Israeli dressing, NPA, CAT, gauze, gloves, tape etc etc.
12/15/2008 9:04:22 PM EDT
[#2]
we stopped issuing the power version of the quick clot because it was causing more harm then good. troop injured would use their mouth to open it and would get burns to the face,throat etc or wind up splattering the contents to the wind uder "stress" and suffering burns from that as well the new quick clot comes in a "bandage style" format with the quick clot encased in the actual bandage.
ALSO: QUICK CLOT CANNOT BE USED INTERNALLY!

Google "Quick Clot" or "Quick Clot Sales"
http://online.boundtree.com/store/product_index.asp?Cat=DRESSINGS%2FSPECIALTY&SubCat=HEMOSTATIC+PRODUCTS&source=google&gclid=CLv_6_q6xJcCFQ2LDQod1GtCRw

also for the CAT Tourniquet
Google:
http://www.uscav.com/productinfo.aspx?productid=9871&tabID=1&CatID=5220
12/15/2008 9:52:40 PM EDT
[#3]
Quoted:

ALSO: QUICK CLOT CANNOT BE USED INTERNALLY!



So if a gaping wound is found one shouldn't pack the wound with QC as QC recommends? Of course you can use it internally in the bounds of prehospital/military care. Instructions came from Z-Medica to irrigate wounds with saline and suction down to the bleed source.  What internal use are you planning for? The internal use Z-Medica cautions against is not in pre hospital use, it's the two studies I cut and pasted below.

And again, your beating to death the old formula, it's known thermogenic properties and ability to blind one when you open iy with your mouth in the wind. We just told our guys to not do that. You shouldn't buy tht powder anymore. It sucks. It's been beaten to death in AARs and anecdotal reports. But it isn't a blanket indictment of all QC products. Go see QCs swine vids. As with anything, take it with a pound of salt (controlled OR environment, clean, well lit, produced by Z-Medica @ UMASS Med Ctr) but they transect a pigs femoral vein and artery and stop the bleed with it.


Case report of uncontrollable pelvic bleeding – managed by a previously unreported method (QuikClot®)
V Shanmugam MS, DNB, FRCS (Glasg.), Specialist Registrar, General SurgeryMH Robinson DM, FRCS, Consultant Colorectal Surgeon
Department of Surgery
Queens Medical Centre
Nottingham
NG7 2UH
Correspondence address:
Mr V Shanmugam
Specialist Registrar
24 Charlecote Drive
Nottingham
NG8 2SB
[email protected]


There is no conflicting interest for either author to declare


No funding was received from any source for this case report
Copyright Journal Compilation © 2008 The Association of Coloproctology of Great Britain and Ireland
KEYWORDS
Pelvic bleeding • arterial bleeding • venous bleeding • QuikClot
ABSTRACT

Pelvic haemorrhage can be difficult to control. Several measures including packing, drawing pins, stenting and embolisation are available.

We present a case where these measures failed to control catastrophic pelvic bleeding while operating in the pelvis to excise a dumbbell tumour involving the right S1 nerve root.

Attempted surgical control by a vascular surgeon and radiological control through stenting and embolisation failed to control the bleeding.

QuikClot® is an inert substance and acts as a selective sponge. This product is licensed for external use by the British military. We felt that "internal" use of Quikclot in this situation might be life-saving and was applied to the bleeding area, stopping the bleeding immediately.

Manuscript received: 07-Apr-2008
Manuscript accepted: 08-Apr-2008
DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1463-1318.2008.01550.x About DOI




Copyright © 2005 American Urological Association, Inc. Published by Elsevier Inc.
Investigative Urology

APPLICATION OF NOVEL HEMOSTATIC AGENT DURING LAPAROSCOPIC PARTIAL NEPHRECTOMY
Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

VITALY MARGULIS, EDWARD D. MATSUMOTO, ROBERT SVATEK, WAREEF KABBANI, JEFFREY A. CADEDDU and YAIR LOTANCorresponding Author Contact Information

Clinical Center for Minimally Invasive Urologic Cancer Treatment, Departments of Urology and Pathology (WK), University of Texas Southwestern Medical Center, Dallas, Texas

Accepted 5 October 2004.
Available online 24 November 2005.

ABSTRACT
Purpose

We determined if QuikClot®, a novel hemostatic agent made of a granulated mineral substance, could be used to control renal parenchymal bleeding and collecting system leakage during open and laparoscopic partial nephrectomy.
Materials and Methods

After obtaining renal hilar vascular control 2 domestic female pigs underwent bilateral open and 4 underwent unilateral laparoscopic partial nephrectomy. After excision of the lower pole without cautery the hemostatic agent was applied to the cut surface of the kidney and hilar vascular control was released. Additional QuikClot® was added until complete hemostasis was achieved. One week postoperatively the animals were sacrificed and the operated kidneys were harvested for ex vivo retrograde pyelograms and histopathological analysis.
Results

All partial nephrectomies were performed without complication. Mean operative and warm ischemia times were 62 and 16 minutes, respectively. An average of 23% of renal mass by weight was resected with a mean blood loss of 73 ml per procedure. No cautery, additional hemostatic agents or techniques were used. No animal had clinical or radiographic evidence of urinoma or delayed hemorrhage. Histopathological analysis showed preservation of the renal parenchyma immediately beneath the QuikClot® layer.
Conclusions

In the porcine model QuikClot® allowed the resection of large renal segments, while providing reliable hemostasis and closure of the renal collecting system. No deleterious effect on underlying renal parenchyma or surrounding tissues was observed.


12/16/2008 5:05:07 AM EDT
[#4]
thanks for the replys. i want it for my line gear. out on fires we deal with a lot of chain saws and figured it would be perfect to use on a gaping wound. our normal first aid kit we carry on the engine is a POS 20 man kit. has a sams splint, bandaids, and asprin. very basic stuff. if someone was to get cut there would be no way i could stop the bleeding...

i just got done with my PHTLS refresher. they showed us quick clot and how effective it is on wounds. i instantly though about how i could use it in my job. tourniquets used to be the last ditch effort to save someones life. now they are teaching if direct pressure doesnt work skip pressure points, elevation and just apply the tourniquet.
12/16/2008 6:20:38 AM EDT
[#5]
WoundStat

Combat Gauze

The two above are the best products available.  WoundStat had a 100% survival rate in live tissue training and Combat Gauze had 80%.  Celox came in at 60% and Quick Clot 0% survival rate.  

C-A-T - This is the New Version Larger Windless Clip and place to write time applied on the TQ itself.

12/16/2008 7:29:48 AM EDT
[#6]
Quoted:


The two above are the best products available.  WoundStat had a 100% survival rate in live tissue training and Combat Gauze had 80%.  Celox came in at 60% and Quick Clot 0% survival rate.  



Have a link for that? I love new research.

12/16/2008 7:49:44 AM EDT
[#7]
I have never been able to find a link for it.  I have the PDF document from USAISR.  I do not know how to post a PDF document that is on my computer to the forum.  Until I can figure this out here are some things to hold ya over.

Here is a powerpoint with the TCCC updates.  Page 21 has a chart comparing the Hemostatic Agents.
2008 TCCC Updates

The important notes for the changes in Hemostatic Agents in TCCC. This is from a memo from Capt. Frank Butler the Chairman of CoTCCC.

2. A number of new hemostatic agents have recently become available. These new agents have undergone testing both at the U.S. Army Institute for Surgical Research (USAISR) and the Naval Medical Research Center (NMRC). The findings from these studies were presented to the Committee on TCCC (CoTCCC) on 1 April 2008. Three different swine bleeding models were used: a 6mm femoral artery punch model at USAISR and both a 4mm femoral artery punch model and a femoral artery/vein transaction model at NMRC. Both the NMRC and the USAISR studies found Combat Gauze and Woundstat to be consistently more effective than the hemostatic agents HemCon and QuikClot previously recommended in the 2006 TCCC guidelines. No significant exothermic reaction was noted with either agent. Celox was also found to outperform the current agents, although it performed less well than WoundStat in the more severe USAISR model, where 10 of 10 Woundstat animal survived, 8 of 10 Combat Gauze animals survived, and 6 of 10 Celox animals survived. The reports detailing this research will be available shortly from USAISR and NMRC.

3. In light of these findings, the CoTCCC voted to recommend Combat Gauze as the first line treatment for life-threatening hemorrhage that is not amenable to tourniquet placement. Woundstat is recommended as the backup agent in the event that Combat Gauze does not effectively control the hemorrhage. The primary reason for this order of priority is that combat medical personnel on the committee expressed a strong preference for a gauze-type hemostatic agent rather than a powder or granule. This preference is based on field experience that powder or granular agents do not work well in wounds where the bleeding vessel is at the bottom of a narrow wound tract. A gauze-type hemostatic agent is more effective in this setting. Combat Gauze was also noted to be more easily removable from the wound site at the time of surgical repair. Woundstat might, however, be very useful in circumstances where the first-line agent has been ineffective or where the characteristics of the wound make a granular agent preferable.
12/16/2008 8:41:56 AM EDT
[#8]
I hope this works, if not I can email the pdf.  Thanks

USAISR Hemostatic Study - 2008
12/16/2008 9:31:34 AM EDT
[#9]
Quoted:
I hope this works, if not I can email the pdf.  Thanks

USAISR Hemostatic Study - 2008



It works, good read. Thanks!